Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CryoMedix
AddedFeb 18, 2024
UpdatedJun 18, 2026
CryoMedix

CryoMedix

Pre-Seed

CryoMedix pioneers in next-gen cryoablation technology with four pending patents.

HQ
San Diego, CA, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

CryoMedix pioneers in next-gen cryoablation technology, focusing on innovative solutions for medical procedures. The company has developed a platform with four pending patents aimed at enhancing the effectiveness and precision of cryoablation treatments. Their market focus includes healthcare providers and medical institutions seeking advanced, minimally invasive options for treating various conditions.

CryoMedix has made significant strides in the medical technology field by securing multiple patents and developing cutting-edge cryoablation solutions. Their advancements promise to improve patient outcomes and offer more efficient treatment options. The company's impact is marked by its commitment to innovation and excellence in medical technology.

CryoMedix - Similar Companies

Focused Cryo logo

Focused Cryo

Ionix Medical logo

Ionix Medical

Adagio Medical logo

Adagio Medical

Cryothermic Systems logo

Cryothermic Systems

BiomedInnovations logo

BiomedInnovations

MediCool Technologies logo

MediCool Technologies

medicooltech.com

Velomedix logo

Velomedix

CryptoMedix logo

CryptoMedix

cryptomedix.com

Gulf States Cryotherapy logo

Gulf States Cryotherapy

Kubanda Cryotherapy logo

Kubanda Cryotherapy

Corfigo logo

Corfigo

corfigo.com

EmboMedics logo

EmboMedics

Aurea Medical logo

Aurea Medical

Tiumed logo

Tiumed

Intellimedix logo

Intellimedix

CryoMedix - Quick Facts

Who are CryoMedix's competitors?

Companies similar to CryoMedix include Focused Cryo, Ionix Medical, Adagio Medical and Cryothermic Systems.

When was CryoMedix founded?

CryoMedix was founded in 2007.

Where is CryoMedix's headquarters located?

CryoMedix's headquarters is located in San Diego, CA, US.

When was CryoMedix's last funding round?

CryoMedix's most recent funding round was for $500k (USD) in July 2014.

How much has CryoMedix raised to-date?

As of Jul 9, 2014, CryoMedix has raised a total of $500k (USD).

How many employees does CryoMedix have?

CryoMedix has 6 employees as of Feb 5, 2024.

CryoMedix - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research